International Companies

Philips creates 'clear path forward' with FDA over Respironics probe

By Benjamin Chiou

Date: Wednesday 10 Apr 2024

(Sharecast News) - Shares in Philips were rising in Amsterdam on Wednesday the Dutch conglomerate settled on a consent decree with US regulators over a Respironics product recall back in 2021.


The company said the agreement with the Department of Justice and Food and Drug Administration, which restricts...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page